Inactief instrument

Andere talen ACCM SCIE OTC Markets

Aandelen

ACMSY

US00442Y1010

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership	17-07-23
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership	17-07-23
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer	11-07-23
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)	09-06-23
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023	09-06-23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06-06-23
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals	06-06-23
AccuStem Announce Strategic Clinical and Operational Partnership	31-05-23
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership	31-05-23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05-05-23
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer	02-05-23
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	15-02-23
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	06-12-22
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares	22-11-22
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	16-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ACCM SCIE OTC Markets

Aandelen

ACMSY

US00442Y1010

Andere talen

Filters